Igene Biotechnology, Inc.
IGNE · OTC
12/31/2009 | 12/31/2008 | 12/31/2007 | 12/31/2006 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $1,295 | $1,488 | $1,026 | $22 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $2,320 | $1,046 | $2,719 | $0 |
| Inventory | $0 | $2,399 | $8,060 | $0 |
| Other Curr. Assets | $44 | $24 | $38 | $14 |
| Total Curr. Assets | $3,660 | $4,956 | $11,843 | $36 |
| Property Plant & Equip (Net) | $853 | $832 | $713 | $34 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $150 | $150 | $150 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $98 | $128 | $393 | $5 |
| Total NC Assets | $1,100 | $1,110 | $1,256 | $39 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $4,760 | $6,066 | $13,099 | $75 |
| Liabilities | – | – | – | – |
| Payables | $0 | $0 | $0 | $210 |
| Short-Term Debt | $1,095 | $0 | $0 | $705 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $465 | $2,849 | $7,903 | $47 |
| Total Curr. Liab. | $1,560 | $2,849 | $7,903 | $962 |
| LT Debt | $5,702 | $5,354 | $19,330 | $15,312 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $240 | $541 | $226 | $219 |
| Total NC Liab. | $5,942 | $5,894 | $19,556 | $15,531 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $7,502 | $8,744 | $27,459 | $16,493 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $15,604 | $15,185 | $1,103 | $1,093 |
| Retained Earnings | -$52,872 | -$52,731 | -$48,740 | -$43,172 |
| AOCI | $58 | -$18 | $0 | $0 |
| Other Equity | $34,467 | $34,886 | $33,277 | $25,660 |
| Total Equity | -$2,743 | -$2,678 | -$14,360 | -$16,419 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $4,760 | $6,066 | $13,099 | $75 |
| Net Debt | $5,501 | $3,866 | $18,304 | $15,996 |